90 related articles for article (PubMed ID: 8088605)
1. Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma.
Scambia G; Gadducci A; Panici PB; Foti E; Ferdeghini M; Ferrandina G; Amoroso M; Castellani C; Facchini V; Mancuso S
Gynecol Oncol; 1994 Sep; 54(3):292-7. PubMed ID: 8088605
[TBL] [Abstract][Full Text] [Related]
2. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma.
Rose PG; Sommers RM; Reale FR; Hunter RE; Fournier L; Nelson BE
Obstet Gynecol; 1994 Jul; 84(1):12-6. PubMed ID: 8008305
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum CA-125 levels in treating endometrial cancer.
Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
[TBL] [Abstract][Full Text] [Related]
4. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
[TBL] [Abstract][Full Text] [Related]
5. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma.
Takeshima N; Shimizu Y; Umezawa S; Hirai Y; Chen JT; Fujimoto I; Yamauchi K; Hasumi K
Gynecol Oncol; 1994 Sep; 54(3):321-6. PubMed ID: 8088608
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.
van Dalen A; Favier J; Baumgartner L; Hasholzner U; de Bruijn H; Dobbler D; Dombi VH; Fink D; Giai M; McGing P; Harlozinska A; Kainz C; Markowska J; Molina R; Sturgeon C; Einarsson R
Anticancer Res; 1999; 19(4A):2523-6. PubMed ID: 10470187
[TBL] [Abstract][Full Text] [Related]
7. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
[TBL] [Abstract][Full Text] [Related]
8. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative platelet count as index of the grading in endometrial carcinoma].
Giannella L; Menozzi G; Di Monte I; Venturini P; De Pace V; Boselli F; Ternelli G; Jasonni VM
Minerva Ginecol; 2008 Aug; 60(4):273-9. PubMed ID: 18560341
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
12. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
[TBL] [Abstract][Full Text] [Related]
13. [Study on cytokeratin and CA125 for diagnosing lymph node micrometastases in endometrial cancer].
Liu FH; Wang YF; Wang J; Xue Q; Jiang S; Ma YY
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):612-5. PubMed ID: 15498190
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study.
Kim HS; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
Gynecol Oncol; 2010 Sep; 118(3):283-8. PubMed ID: 20541245
[TBL] [Abstract][Full Text] [Related]
15. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma.
Yildiz A; Yetimalar H; Kasap B; Aydin C; Tatar S; Soylu F; Yildiz FS
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):191-5. PubMed ID: 22727919
[TBL] [Abstract][Full Text] [Related]
17. Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy.
Koper NP; Massuger LF; Thomas CM; Kiemeney LA; Verbeek AL
Anticancer Res; 1998; 18(3B):1897-902. PubMed ID: 9677441
[TBL] [Abstract][Full Text] [Related]
18. Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma.
Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Casaldi V; Cavaliere F; Carlini M; Garofalo A; Rinaldi G
Anticancer Res; 1993; 13(6B):2409-13. PubMed ID: 8135475
[TBL] [Abstract][Full Text] [Related]
19. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative levels of CA 125 and risk factors in adenocarcinoma of the endometrium].
Marcello C; Corda F; Pilloni MD; Puligheddu P; Lecca U
Ann Ostet Ginecol Med Perinat; 1989; 110(6):290-5. PubMed ID: 2639616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
